CompletedNCT04098302
Dutasteride to Reduce Heavy Drinking
About this title
Read the official source — NCT04098302Medication studyAges 35–70United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 35 years to 70 years.
- Listed locations
- FarmingtonSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Study information
Study start dateStarted: October 15, 2019
- Recruitment status
- Completed
- Enrollment listed in the registry
- 180
- Sponsor
- UConn Health
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 35 Years to 70 Years
- Official registry ID
- NCT04098302
- Official title
Show the full official title
Dutasteride Treatment for Reducing Heavy Drinking in AUD: Predictors of Efficacy
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Farmington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is UConn Health.
Did this study involve medication?
Yes. The study involved medication, including Dutasteride Capsules and Placebo Capsules.
Who was this study for?
Listed age limits: 35 years to 70 years.
